Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
R&D
Page 3
R&D
Featured
Jazz and Werewolf enter exclusive global license and collaboration agreement to develop cancer therapy
Tess Egginton
-
11th April 2022
0
Featured
U.S. FDA grants priority review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
Tess Egginton
-
5th April 2022
0
Featured
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
Tess Egginton
-
5th April 2022
0
Featured
$4 million research program seeks therapy for rare genetic condition ADNP syndrome
Tess Egginton
-
30th March 2022
0
Featured
Sanofi and IGM Biosciences sign collaboration agreement for IgM antibody agonists
Tess Egginton
-
30th March 2022
0
Featured
New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections
Tess Egginton
-
28th March 2022
0
Featured
Pfizer granted FDA Breakthrough Therapy Designation for respiratory syncytial virus vaccine candidate for the prevention of RSV in older adults
Tess Egginton
-
25th March 2022
0
Featured
Global trials show drug eases symptoms of chronic cough
Tess Egginton
-
25th March 2022
0
Featured
Pioneering technique could unlock targeted treatments for cancer
Tess Egginton
-
18th March 2022
0
Featured
Novo Nordisk Foundation, Open Philanthropy, and Bill & Melinda Gates Foundation launch initiative to support new antiviral medicines for future pandemics
Tess Egginton
-
15th March 2022
0
1
2
3
4
...
19
Page 3 of 19